127 related articles for article (PubMed ID: 37791396)
1. How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease.
Kang SY; Lee YH; Jeong SJ; Kim JS; Jeong KH; Hwang HS
Nephrol Dial Transplant; 2024 Apr; 39(5):778-787. PubMed ID: 37791396
[TBL] [Abstract][Full Text] [Related]
2. Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome.
Lee YB; Han K; Kim B; Jun JE; Lee SE; Ahn J; Kim G; Jin SM; Kim JH
Diabetes Metab Res Rev; 2019 Nov; 35(8):e3197. PubMed ID: 31222888
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease and clinical outcomes in chronic kidney disease.
Chinnadurai R; Ritchie J; Green D; Kalra PA
Nephrol Dial Transplant; 2019 Mar; 34(3):449-457. PubMed ID: 29390103
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and risk of progression of chronic kidney disease: a single-center cohort study in Japan.
Saito T; Mochizuki T; Uchida K; Tsuchiya K; Nitta K
Heart Vessels; 2013 May; 28(3):323-9. PubMed ID: 22526382
[TBL] [Abstract][Full Text] [Related]
5. Obesity, Metabolic Abnormality, and Progression of CKD.
Yun HR; Kim H; Park JT; Chang TI; Yoo TH; Kang SW; Choi KH; Sung S; Kim SW; Lee J; Oh KH; Ahn C; Han SH;
Am J Kidney Dis; 2018 Sep; 72(3):400-410. PubMed ID: 29728317
[TBL] [Abstract][Full Text] [Related]
6. Influence of obesity and metabolic syndrome on clinical outcomes of ST-segment elevation myocardial infarction in men undergoing primary percutaneous coronary intervention.
Lee SH; Jeong MH; Kim JH; Kim MC; Sim DS; Hong YJ; Ahn Y; Chae SC; Seong IW; Park JS; Chae JK; Hur SH; Cha KS; Kim HS; Gwon HC; Seung KB; Rha SW;
J Cardiol; 2018 Oct; 72(4):328-334. PubMed ID: 29709405
[TBL] [Abstract][Full Text] [Related]
7. Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.
Hanks LJ; Tanner RM; Muntner P; Kramer H; McClellan WM; Warnock DG; Judd SE; Gutiérrez OM;
Clin J Am Soc Nephrol; 2013 Dec; 8(12):2064-71. PubMed ID: 24178980
[TBL] [Abstract][Full Text] [Related]
8. Obesity related risk for chronic kidney disease progression and cardiovascular disease after propensity score matching.
Barbieri D; Goicoechea M; García-Prieto A; Delgado A; Verde E; Verdalles U; Pérez de José A; Carbayo J; Muñoz de Morales A; Luño J
Hipertens Riesgo Vasc; 2021; 38(2):63-71. PubMed ID: 33759767
[TBL] [Abstract][Full Text] [Related]
9. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
Buyadaa O; Magliano DJ; Salim A; Koye DN; Shaw JE
Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
[TBL] [Abstract][Full Text] [Related]
10. High risk of renal outcome of metabolic syndrome independent of diabetes in patients with CKD stage 1-4: The ICKD database.
Lin HY; Chang LY; Niu SW; Kuo IC; Yen CH; Shen FC; Chen PL; Chang JM; Hung CC
Diabetes Metab Res Rev; 2023 May; 39(4):e3618. PubMed ID: 36731513
[TBL] [Abstract][Full Text] [Related]
11. All-Cause and Cardiovascular Mortality Among Koreans: Effects of Obesity and Metabolic Health.
Sung KC; Ryu S; Cheong ES; Kim BS; Kim BJ; Kim YB; Chung PW; Wild SH; Byrne CD
Am J Prev Med; 2015 Jul; 49(1):62-71. PubMed ID: 26094228
[TBL] [Abstract][Full Text] [Related]
12. Association of metabolic syndrome and chronic kidney disease with atrial fibrillation: A nationwide population-based study in Korea.
Choe WS; Choi EK; Han KD; Lee EJ; Lee SR; Cha MJ; Oh S
Diabetes Res Clin Pract; 2019 Feb; 148():14-22. PubMed ID: 30578822
[TBL] [Abstract][Full Text] [Related]
13. Abdominal obesity is the most significant metabolic syndrome component predictive of cardiovascular events in chronic hemodialysis patients.
Wu CC; Liou HH; Su PF; Chang MY; Wang HH; Chen MJ; Hung SY
Nephrol Dial Transplant; 2011 Nov; 26(11):3689-95. PubMed ID: 21357211
[TBL] [Abstract][Full Text] [Related]
14. Impact of metabolic syndrome on resting energy expenditure in patients with chronic kidney disease.
Rodrigues CQD; Santos JAP; Quinto BMR; Marrocos MSM; Teixeira AA; Rodrigues CJO; Batista MC
Clin Nutr ESPEN; 2016 Oct; 15():107-113. PubMed ID: 28531773
[TBL] [Abstract][Full Text] [Related]
15. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease.
Tsai CW; Huang HC; Chiang HY; Chung CW; Chiu HT; Liang CC; Yu T; Kuo CC
Nephrol Dial Transplant; 2019 Dec; 34(12):2066-2078. PubMed ID: 29982714
[TBL] [Abstract][Full Text] [Related]
16. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.
Arnlöv J; Ingelsson E; Sundström J; Lind L
Circulation; 2010 Jan; 121(2):230-6. PubMed ID: 20038741
[TBL] [Abstract][Full Text] [Related]
17. Interventions for weight loss in people with chronic kidney disease who are overweight or obese.
Conley MM; McFarlane CM; Johnson DW; Kelly JT; Campbell KL; MacLaughlin HL
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013119. PubMed ID: 33782940
[TBL] [Abstract][Full Text] [Related]
18. Circulating ADAMs are associated with renal and cardiovascular outcomes in chronic kidney disease patients.
Palau V; Riera M; Duran X; Valdivielso JM; Betriu A; Fernández E; Pascual J; Soler MJ
Nephrol Dial Transplant; 2020 Jan; 35(1):130-138. PubMed ID: 30102333
[TBL] [Abstract][Full Text] [Related]
19. Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.
Dobre M; Yang W; Chen J; Drawz P; Hamm LL; Horwitz E; Hostetter T; Jaar B; Lora CM; Nessel L; Ojo A; Scialla J; Steigerwalt S; Teal V; Wolf M; Rahman M;
Am J Kidney Dis; 2013 Oct; 62(4):670-8. PubMed ID: 23489677
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome, ESRD, and death in CKD.
Navaneethan SD; Schold JD; Kirwan JP; Arrigain S; Jolly SE; Poggio ED; Beddhu S; Nally JV
Clin J Am Soc Nephrol; 2013 Jun; 8(6):945-52. PubMed ID: 23411425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
